Evaluation of the impact of the lockdown and easing of restrictions on the management of patients with inflammatory disease and immune disorders followed up as part of the FHU IMMINeNT project (rheumatology, dermatology, internal medicine, pulmonology, gastroenterology and neurology) FRESH-PEF73487-en Frédéric DEZOTEUX Evaluation of the impact of the lockdown and easing of restrictions on the management of patients with inflammatory disease and immune disorders followed up as part of the FHU IMMINeNT project (rheumatology, dermatology, internal medicine, pulmonology, gastroenterology and neurology) CONFIMIDs FRESH-PEF73487-en 73487 FRESH-PEF73487 Frédéric DEZOTEUX CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE (CHU) Epidemiology France Portal (PEF) null Clinical immunology Internal medicine Neurology Pulmonary medicine Rheumatology Dermatology Gastroenterology Diseases of the nervous system Systemic sclerosis Systemic lupus erythematosus Psoriasis Diseases of the skin Unspecified asthma, uncomplicated Inflammatory arthropathies Respiratory diseases principally affecting the lung interstitium Crohn disease Ulcerative colitis Vasculitis or capillaritis involving the skin COVID-19 Behavioral determinants Socio-demographic and economic determinants: Employment Socio-demographic and economic determinants Estimate the frequency of patients, with chronic inflammatory disorders, followed up as part of the FHU IMMINeNT project (gastroenterology, rheumatology, dermatology, pulmonology, neurology, internal medicine), whose follow-up has been affected by the lockdown and easing of restrictions. null France Hauts-de-France Individuals Patients population Male Female Other Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) All adult patients followed up as part of the FHU project for: - Chronic inflammatory bowel disease or IBD (Crohn’s disease and ulcerative colitis), - Rheumatic disorders (rheumatoid arthritis and spondyloarthritis) - Multiple sclerosis - Asthma - Psoriasis - Atopic dermatitis - Systemic auto-immune disease (scleroderma and lupus) Clinical data Participant-reported health data Other Medical-administrative database (patients health insurance/mutual insurance) Disease and death registry [1000-10000[ individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study 4500 Unknown To be defined